Drug Type Small molecule drug |
Synonyms macromolecular carrier-linked carbon monoxide releasing molecules (Alfama), ALF-421 |
Target |
Mechanism TNF inhibitors(Tumor necrosis factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Failure, Acute | Preclinical | US | - | |
Neoplasms | Preclinical | US | - | |
Nonalcoholic Steatohepatitis | Preclinical | US | - | |
Ileus | Discovery | US | - | |
Inflammation | Discovery | PT | - |